Newswise — July 27, 2023 – Race/ethnicity is not an independent predictor of hospital readmission in patients undergoing breast reconstruction surgery, reports a study in the August issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Among patients who have unplanned hospitalizations after breast reconstruction, costs are substantially higher for Black or Hispanic patients, according to the new research by ASPS Member Surgeon Kevin C. Chung, MD, MS, of University of Michigan and colleagues. Dr. Chung comments, "Our study lends new insights into healthcare disparities for an important reconstructive surgery and points to possible strategies to foster more equitable care." Dr. Chung is Editor-in-Chief of Plastic and Reconstructive Surgery.
Study looks at disparities in readmission and costs after breast reconstruction
The researchers evaluated potential racial/ethnic disparities in a sample of more than 17,000 patients who underwent breast reconstruction from 2006 to 2015. Data were drawn from the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project, representing five states in four US regions.
The analysis focused on differences in unplanned emergency department visits and hospitalizations within 30 days after breast reconstruction. Differences in costs incurred during hospital readmissions were compared as well.
White patients accounted for 70% of the study sample, Black patients for 11%, Hispanic patients for 8%, and patients of "other" race/ethnicity for 11%. Rates of unplanned hospital visits were six percent for Black patients and seven percent for Hispanic patients, compared to five percent for White patients and those in "other" racial/ethnic categories.
However, after adjustment for other variables, race/ethnicity was not an independent risk factor for unplanned readmission. The presence of up to four comorbidities (other medical conditions) was a significant factor, associated with a 27% increase in readmission risk.
Non-White patients 'bear a higher cost burden' from unplanned readmissions
In contrast, non-White patients had higher costs for hospital readmission. Average costs were about $12,800 for Black patients, $12,350 for Hispanic patients, and $18,000 for patients in the "other" category, compared to $10,000 for White patients. In adjusted analyses, Black and Hispanic patients were about 35% more likely to experience an increased cost for their readmission and "other" patients about 70% more likely, compared to White patients.
"Racial disparities in postoperative plastic surgery care are well documented," Dr. Chung and colleagues write. "[H]owever, little is known about the consequences of this disparity as it related to unplanned hospital visits and associated costs." Breast reconstruction has benefits in restoring form and function in women who have undergone mastectomy for breast cancer.
"Although race is not an independent predictor of an unplanned hospital visit after surgery, racial minorities bear a higher cost burden after controlling for insurance status, further stimulating healthcare disparities," Dr. Chung and coauthors conclude. They highlight the need for further studies to determine the reasons for racial disparities in costs and what strategies can be followed to mitigate them, such as adjusted payment models. Additionally, the authors recognize the limitations of using an administrative database to study such a phenomenon and state that prospective studies are needed to better evaluate differences in cost for readmission among racial minorities.
Read [Racial Disparities in the Cost of Unplanned Hospitalizations After Breast Reconstruction]
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
###
About Plastic and Reconstructive Surgery
For over 75 years, Plastic and Reconstructive Surgery® (http://www.prsjournal.com/) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
About ASPS
The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2022 annual revenues of €5.5 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Twitter, Facebook, and YouTube.
RSS